Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains Hold Rating on DaVita Raises Price Target

Elaine Mendonca by Elaine Mendonca
February 14, 2024
in Breaking News
0
Healthcare Services Stock Exchange
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

On February 14, 2024, David Macdonald, an analyst at Truist Securities, expressed his perspective on DaVita (NYSE:DVA). While maintaining a Hold rating on the stock, Macdonald decided to elevate the price target from $120 to $130. This adjustment signifies his belief that the stock’s performance is anticipated to align with the market’s average performance. The Hold rating indicates a neutral outlook on the stock, suggesting that investors should neither buy nor sell at this time.

DaVita Inc. (DVA) Shows Strong Performance on February 14, 2024: Trading Near 52-Week High and Above 200-Day Moving Average

On February 14, 2024, DaVita Inc. (DVA) showcased a strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. According to data from CNN Money, the price of DVA shares experienced a slight decrease of $0.70 since the market last closed. This represented a 0.61% drop in the stock’s value. DVA began the trading day at $124.05, opening $10.40 higher than its previous close. The fact that DVA was trading near the top of its 52-week range indicated that the stock had been performing well over the past year. Furthermore, the stock’s price was above its 200-day simple moving average, which is a commonly used technical indicator. Overall, on February 14, 2024, DVA exhibited a positive price momentum, trading near the top of its 52-week range and above its 200-day simple moving average.

DaVita Stock Performance on February 14, 2024: Strong Growth in Revenue, Net Income, and EPS

DVA Stock Performance on February 14, 2024: A Steady Growth Story

Total revenue is a key indicator of a company’s financial health, and DaVita did not disappoint. In the past year, DaVita generated a total revenue of $12.14 billion, marking a 4.57% increase compared to the previous year. This growth indicates that the company has been successful in expanding its operations and attracting more customers. Moreover, DaVita’s total revenue remained flat from the previous quarter, suggesting a stable and consistent performance.

Net income, another crucial metric, also demonstrated a positive trend for DaVita. Over the course of the year, the company’s net income reached $691.53 million, indicating a significant 26.44% increase compared to the previous year. This growth in net income suggests that DaVita has been able to effectively manage its expenses and improve its overall profitability. Similar to total revenue, the net income held flat since the last quarter, highlighting the company’s ability to maintain its financial performance.

Earnings per share (EPS) is a measure that reveals the profitability of a company on a per-share basis. DaVita’s EPS has been on an upward trajectory, demonstrating consistent growth. Over the past year, the company’s EPS stood at $7.42, marking an impressive 30.01% increase compared to the previous year. This growth in EPS indicates that DaVita’s profitability has improved, benefiting its shareholders. Despite holding flat since the last quarter, the consistent growth in EPS reflects the company’s ability to generate higher earnings for its investors.

Overall, DaVita’s stock performance on February 14, 2024, showcased a steady growth story. The company’s total revenue, net income, and earnings per share all demonstrated positive trends, indicating a healthy and robust financial performance. DaVita’s ability to increase its total revenue by 4.57% over the past year and improve its net income by 26.44% reflects its successful business strategies and efficient cost management. Moreover, the impressive growth in earnings per share by 30.01% underscores the company’s commitment to generating value for its shareholders.

Investors and analysts will likely view DaVita’s financial performance positively, as it suggests a stable and profitable investment opportunity. However, it is important to conduct further research and analysis to gain a comprehensive understanding of the company’s overall financial health and market dynamics before making any investment decisions.

Tags: DVA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Transportation Stock Exchange

Analyzing Short Interest in Old Dominion Freight Line A Shift Towards Bullish Sentiment

Automotive Stock Market Today

Lithia Motors Inc Reports Mixed Q4 Results for FY23

Food Retailers Market Capitalization

Borealis Foods Revolutionizing Food Tech to Combat Malnutrition and Food Insecurity

Recommended

MDB stock news

Insider Trading Activity and Institutional Investment in MongoDB, Inc.: Key Developments to Monitor for Shareholders

3 years ago
Paramount Global Stock

Paramount Global Initiates Major Workforce Reduction Following Merger

3 months ago
Coinbase Stock

Coinbase Bets on Prediction Markets Amid Crypto Uncertainty

3 months ago
Nvidia Stock

Nvidia’s Strategic Gambits Fuel Market Speculation

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Trending

Guaranty Bancshares Stock
Analysis

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

by Jackson Burston
February 7, 2026
0

A strategic acquisition in Texas is proving to be a significant catalyst for Guaranty Bancshares. The bank's...

Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy
  • ServiceNow Shares Face Market Skepticism Despite Record Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com